Cutting edge: Metabolic immune reprogramming, reactive oxygen species, and cancer
- PMID: 33561318
- DOI: 10.1002/jcp.30303
Cutting edge: Metabolic immune reprogramming, reactive oxygen species, and cancer
Abstract
A recently proposed term "immunometabolism" points to the functional intracellular metabolic changes that occur within different immune cells. Recent findings suggest that immune responses can be determined by the metabolic status of immune cells and metabolic reprogramming is an important feature of immune cell activation. Metabolic reprogramming is also well known for cancer cells and has been suggested as a major sign of cancer progression. Metabolic reprogramming of immune cells is also seen in the tumor microenvironment. In the past decade, immunometabolism has progressively become an extraordinarily vibrant and productive area of study in immunology because of its importance for immunotherapy. Understanding the immunometabolic situation of T cells and other immune cells along with the metabolic behavior of cancer cells can help us design new therapeutic approaches against cancers. Here, we have the aim to review the cutting-edge findings on the immunometabolic situation in immune and tumor cells. We discuss new findings on signaling pathways during metabolic reprogramming, its regulation, and the participation of reactive oxygen species in these processes.
Keywords: T cells; immunometabolism; metabolic reprogramming; reactive oxygen species; tumor cells.
© 2021 Wiley Periodicals LLC.
References
REFERENCES
-
- Abdou, Y. , Pandey, M. , Sarma, M. , Shah, S. , Baron, J. , & Ernstoff, M. S. (2020). Mechanism-based treatment of cancer with immune checkpoint inhibitor therapies. British Journal of Clinical Pharmacology, 86, 1690-1702.
-
- Adams, T. A. , Vail, P. J. , Ruiz, A. , Mollaee, M. , McCue, P. A. , Knudsen, E. S. , & Witkiewicz, A. K. (2018). Composite analysis of immunological and metabolic markers defines novel subtypes of triple negative breast cancer. Modern Pathology, 31(2), 288-298.
-
- Al-Khami, A. A. , Zheng, L. , Del Valle, L. , Hossain, F. , Wyczechowska, D. , Zabaleta, J. , Sanchez, M. D. , Dean, M. J. , Rodriguez, P. C. , & Ochoa, A. C. (2017). Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells. Oncoimmunology, 6(10), e1344804.
-
- Al-Khami, A. A. , Rodriguez, P. C. , & Ochoa, A. C. (2017). Energy metabolic pathways control the fate and function of myeloid immune cells. Journal of Leukocyte Biology, 102(2), 369-380.
-
- Amelio, I. , Cutruzzolá, F. , Antonov, A. , Agostini, M. , & Melino, G. (2014). Serine and glycine metabolism in cancer. Trends in Biochemical Sciences, 39(4), 191-198.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
